BlackRock Investment Management’s vTv Therapeutics VTVT Stock Holding History

BlackRock Investment Management’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$134K	Hold	694	–	–	﹤0.01%	3259
2016 Q3	$200K	Hold	694	–	–	﹤0.01%	3236
2016 Q2	$161K	Buy	694 +140	+25%	+$32.2K	﹤0.01%	3289
2016 Q1	$114K	Buy	554 +58	+12%	+$14.4K	﹤0.01%	3229
2015 Q4	$135K	Buy	496 +8	+2%	+$2.25K	﹤0.01%	3262
2015 Q3	$127K	Buy	+488	New	+$170K	﹤0.01%	3290

Other funds holding VTVT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock Investment Management's VTVT Position: Q4 2016 in Review

BlackRock Investment Management held its vTv Therapeutics (VTVT) position steady in Q4 2016 at 694 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #3259.

BlackRock Investment Management first reported a position in VTVT in Q3 2015 and has held it in 6 quarters since. The position peaked at $200K in Q3 2016. 44 funds tracked by Wall St. Rank hold VTVT as of Q4 2016.

BlackRock Investment Management held 694 shares of vTv Therapeutics worth $134K as of Q4 2016.
BlackRock Investment Management left its vTv Therapeutics share count unchanged in Q4 2016.
vTv Therapeutics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3259 holding.
BlackRock Investment Management first reported a position in vTv Therapeutics in Q3 2015 and has held it in 6 quarters since.
BlackRock Investment Management's vTv Therapeutics position peaked at $200K in Q3 2016.
44 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.